Decoy Therapeutics Announces Breakthrough In Vitro Activity Against Ebola Zaire, Expanding D-MAV™ Platform into High Consequence Global Health Threats

Go back to Decoy Therapeutics Announces Breakthrough In Vitro Activity Against Ebola Zaire, Expanding D-MAV™ Platform into High Consequence Global Health Threats
(NASDAQ: DCOY) Delayed: 2.56 -0.22 (7.91%)
Previous Close $2.78    52 Week High
Open $2.78    52 Week Low
Day High $2.79    P/E N/A 
Day Low $2.18    EPS
Volume 94,275